Advanced Enzyme Technologies buys back 64,583 shares on 28 Oct 2026

The buyback in numbers

Daily purchases under the buyback

Advanced Enzyme Technologies is buying back its fully paid-up equity shares of face value ₹2 each from the open market through the stock exchanges mechanism, under the SEBI (Buy-Back of Securities) Regulations, 2018 as amended. The filing is the daily report on shares bought back on 28 Oct 2026, submitted under Regulation 18(i) of those regulations.

On 28 Oct 2026 the company bought 64,583 shares through Emkay Global Financial Services Limited at an average price of ₹262.4914 a share, excluding transaction cost. No shares were closed out on that day or earlier, so the total bought back as on 28 Oct 2026 stands at 23,56,451 shares.

Running total against the day's purchase

The cumulative total rose from 22,91,868 shares as on 27 Oct 2026 to 23,56,451 shares, an increase of 64,583 shares, which matches the day's purchase. The figure is the company's own count under the buyback and is shown in the filing as printed.

The company's latest reported quarter, Q1 FY27 on a consolidated basis, showed total income of ₹202.81 crore, up 4.1% year on year.

What the buyback means for Advanced Enzyme Technologies' shareholders

The filing gives no total size of the buyback in rupees or shares, no closing date, no maximum price, no reason and no source of funds, so the programme's full scope is not known from this filing.

The next dated step the filing gives is the company website and the BSE and NSE websites, where the details are also made available. No further daily report date is given in this filing.

Reference: Original filing (PDF)